By now, we’ve all heard of the Sovaldi Pricing controversy – Drug Pricing all over seem to be spiraling out of control! So why is Gilead taking so much heat over its $84,000 treatment plan? Read more here. (Source: Wharton University of Pennsylvania, 4/16/14).